30,622 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Acquired by Allianz SE

Allianz SE acquired a new position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 30,622 shares of the pharmacy operator’s stock, valued at approximately $284,000.

A number of other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in Walgreens Boots Alliance by 2.7% during the fourth quarter. Vanguard Group Inc. now owns 86,335,084 shares of the pharmacy operator’s stock worth $805,506,000 after buying an additional 2,279,495 shares in the last quarter. State Street Corp raised its stake in shares of Walgreens Boots Alliance by 18.0% in the third quarter. State Street Corp now owns 42,997,580 shares of the pharmacy operator’s stock worth $385,258,000 after acquiring an additional 6,569,223 shares during the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Walgreens Boots Alliance by 19.9% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 13,155,138 shares of the pharmacy operator’s stock valued at $122,737,000 after purchasing an additional 2,185,950 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Walgreens Boots Alliance by 12.1% during the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 7,594,475 shares of the pharmacy operator’s stock worth $68,046,000 after buying an additional 817,762 shares in the last quarter. Finally, Norges Bank acquired a new position in shares of Walgreens Boots Alliance during the fourth quarter valued at $58,241,000. 58.59% of the stock is currently owned by institutional investors.

Walgreens Boots Alliance Stock Up 0.3 %

Shares of WBA opened at $11.19 on Monday. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $21.74. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. The firm has a 50 day simple moving average of $10.83 and a two-hundred day simple moving average of $9.92. The company has a market cap of $9.67 billion, a P/E ratio of -1.09, a P/E/G ratio of 1.31 and a beta of 0.62.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The company had revenue of $39.50 billion for the quarter, compared to analyst estimates of $37.40 billion. During the same period in the previous year, the firm posted $0.66 EPS. The firm’s revenue was up 7.6% on a year-over-year basis. Research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts recently commented on WBA shares. Bank of America lifted their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research note on Monday, January 13th. Truist Financial decreased their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a research note on Friday, January 31st. Evercore ISI upped their price target on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. Wolfe Research raised Walgreens Boots Alliance to a “hold” rating in a research report on Monday, February 24th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and decreased their price target for the stock from $11.00 to $9.00 in a research note on Friday, February 28th. Four research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.